<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: chemotherapy</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Adding drug to chemotherapy following colon cancer surgery does not improve disease-free survival</title>
   	 <description>Adding the drug cetuximab to a regimen of drugs used for the treatment of patients following surgery for stage III colon cancer did not result in improved disease-free survival, according to a study in the April 4 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2012-04-adding-drug-chemotherapy-colon-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 Apr 2012 16:02:50 EST</pubDate>
	 <guid isPermaLink="false">news252687759</guid>
	 
</item>
<item>
     <title>High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy</title>
   	 <description>High epidermal growth factor receptor (EGFR) expression was a good predictor of which lung cancer patients would survive longer when cetuximab (Erbitux) was added to first-line chemotherapy, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).</description>
     <link>http://medicalxpress.com/news/2011-07-high-egfr-predictor-survival-cetuximab.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 05 Jul 2011 04:51:10 EST</pubDate>
	 <guid isPermaLink="false">news229060256</guid>
	 
</item>
<item>
     <title>Breast cancer drug pushes colon cancer cells to their death</title>
   	 <description>A new treatment for colon cancer that combines a chemotherapy agent approved to treat breast cancer and a cancer-fighting antibody is ready for clinical trials, according to Penn State College of Medicine researchers.</description>
     <link>http://medicalxpress.com/news/2011-06-breast-cancer-drug-colon-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 08 Jun 2011 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news226756743</guid>
	 
</item>
<item>
     <title>Gene-modified stem cells help protect bone marrow from toxic side effects of chemotherapy</title>
   	 <description>Although chemotherapy is used to kill cancer cells, it can also have a strong toxic effect on normal cells such as bone marrow and blood cells, often limiting the ability to use and manage the chemotherapy treatment. Researchers at Fred Hutchinson Cancer Research Center reported at today's annual meeting of the American Society of Gene and Cell Therapy in Seattle that one possible approach to reduce this toxic effect on bone marrow cells is to modify the cells with a gene that makes them resistant to chemotherapy.</description>
     <link>http://medicalxpress.com/news/2011-05-gene-modified-stem-cells-bone-marrow.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 21 May 2011 05:36:52 EST</pubDate>
	 <guid isPermaLink="false">news225174980</guid>
	 
</item>
<item>
     <title>DNA repair system affects colon cancer recurrence and survival</title>
   	 <description>Colorectal cancer patients with defects in mismatch repair--one of the body's systems for repairing DNA damage--have lower recurrence rates and better survival rates than patients without such defects, according to a study published online May 19th in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2011-05-dna-affects-colon-cancer-recurrence.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 19 May 2011 16:23:38 EST</pubDate>
	 <guid isPermaLink="false">news225040984</guid>
	 
</item>
<item>
     <title>Heat helps cancer drugs battle cancer</title>
   	 <description>(PhysOrg.com) -- Localized hyperthermia has been used occasionally with cancer drugs for some time, but until now, the reason it helps has been a mystery.  In a report in the Proceedings of the National Academy of Sciences, scientists have discovered that the addition of heat inhibits homologous recombination so the cancer cells are unable to repair DNA damage caused by the cancer treatments.</description>
     <link>http://medicalxpress.com/news/2011-05-cancer-drugs.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 10 May 2011 15:00:01 EST</pubDate>
	 <guid isPermaLink="false">news224255592</guid>
	 
</item>
<item>
     <title>Estrogen-lowering drugs reduce mastectomy rates for breast cancer patients</title>
   	 <description>In the first large trial of its kind in the United States, researchers have shown that estrogen-lowering drugs can shrink tumors and reduce mastectomy rates for patients with stage 2 or 3 breast cancer.</description>
     <link>http://medicalxpress.com/news/2011-05-estrogen-lowering-drugs-mastectomy-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 09 May 2011 16:30:49 EST</pubDate>
	 <guid isPermaLink="false">news224177415</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/estrogenlowe.jpg" width="90" height="90" />
</item>


</channel>
</rss>
